Anika Therapeutics (ANIK) Non-Current Debt (2010 - 2020)

Anika Therapeutics (ANIK) has reported Non-Current Debt for 5 consecutive years, with $25.0 million the latest figure, recorded in Q3 2020.

• On a quarterly basis, Non-Current Debt changed N/A year-over-year to $25.0 million in Q3 2020; TTM through Sep 2020 was $25.0 million, a N/A change from a year earlier, with the FY2012 full-year figure at $9.6 million, down 14.29% from the prior year.
• Non-Current Debt was $25.0 million for Q3 2020 at Anika Therapeutics, down from $50.0 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $50.0 million in Q2 2020 and troughed at $25.0 million in Q3 2020.